Showing results (101-110 of 382) with videos related to

Sort By:
Pageof 39
Mayo Clinic Proceedings|October 5, 2020
SARS-CoV-2 Vaccine Development: Current StatusGregory A Poland, Inna G Ovsyannikova, Stephen N Crooke, et al.
Clinical and Vaccine Immunology : CVI|May 9, 2008
Development of a novel efficient fluorescence-based plaque reduction microneutralization assay for measles virus immunityIana H Haralambieva, Inna G Ovsyannikova, Robert A Vierkant, et al.
Mayo Clinic Proceedings|December 17, 2009
2009 H1N1 influenzaSeth J Sullivan, Robert M Jacobson, Walter R Dowdle, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 30, 2018
Detection and Quantification of Influenza A/H1N1 Virus-Specific Memory B Cells in Human PBMCs Using ELISpot AssayIana H Haralambieva, Inna G Ovsyannikova, Richard B Kennedy, et al.
Clinical Advances in Hematology & Oncology : H&O|October 17, 2014
Room for improvement: immunizations for patients with monoclonal B-cell lymphocytosis or chronic lymphocytic leukemiaJennifer A Whitaker, Tait D Shanafelt, Gregory A Poland, et al.
Scandinavian Journal of Infectious Diseases|July 24, 2003
Differential HLA gene expression in measles vaccine seropositive and seronegative subjects: a pilot studyNeelam Dhiman, Ruben G Bonilla, Robert M Jacobson, et al.
Hearing Research|July 1, 2008
Relation between outer hair cell loss and hearing loss in rats exposed to styreneGuang-Di Chen, Chiemi Tanaka, Donald Henderson
Neuroscience Research|August 16, 2011
Protection from impulse noise-induced hearing loss with novel Src-protein tyrosine kinase inhibitorsEric C Bielefeld, David Hangauer, Donald Henderson
Clinical and Diagnostic Laboratory Immunology|May 10, 2003
Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccineInna G Ovsyannikova, Neelam Dhiman, Robert M Jacobson, et al.
Pageof 39